GUIDANCE FOR FULL-YEAR 2025 } Group revenues expected in the range of € 840 m to € 880 m (FY 2024: € 797.0 m) } R&D expenditures are expected in a range of € 40 m to € 50 m (FY 2024: € 50.9 m) } Adjusted Group EBITDA1 is expected to reach € 30 m to € 50 m (FY 2024: € 22.6 m) OUTLOOK 2028 } Group revenues CAGR2024-2028 targeted to be in a range of 8 – 12% } Adj. EBITDA margin 2028 expected to be above 20%
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。